Latest round

Series A

Last raised

Aug 2025

Total raised

Undisclosed

Investors

2

About Bloomage Gag

, founded in 2023 and headquartered in Shenzhen, China, is engaged in the synthesis of heparin polysaccharides. No specific pivots or changes in strategy have been noted during its brief history., Ltd. specializes in the innovative synthesis of heparin polysaccharides and the development of novel pharmaceuticals. Utilizing advanced synthetic biology technologies, the company has created a unique platform for in vitro enzymatic synthesis, addressing key issues related to supply chain security and ethical concerns. Their customer base includes pharmaceutical companies and research institutions across North America, Europe, and parts of Asia., Ltd. is structured around B2B transactions, collaborating with pharmaceutical firms and research entities to supply heparin polysaccharides and related enzyme products. These transactions occur through direct sales agreements or strategic partnerships, where customized pricing is established based on volume and contracts, focusing on proprietary heparin derivatives and enzyme formulations integrated into therapeutic applications., Ltd. is structured around B2B transactions, collaborating with pharmaceutical firms and research entities to supply heparin polysaccharides and related enzyme products. These transactions occur through direct sales agreements or strategic partnerships, where customized pricing is established based on volume and contracts, focusing on proprietary heparin derivatives and enzyme formulations integrated into therapeutic applications.

Who invested in Bloomage Gag

2 investors across 1 round

See all investors in Bloomage Gag

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 19, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Bloomage Gag

Who invested in Bloomage Gag?

Bloomage Gag has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Bloomage Gag raised?

Bloomage Gag has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Bloomage Gag last raise money?

Bloomage Gag's most recent round on record is a Series A, in Aug 2025.

What does Bloomage Gag do?

, founded in 2023 and headquartered in Shenzhen, China, is engaged in the synthesis of heparin polysaccharides.

Where is Bloomage Gag headquartered?

Bloomage Gag is headquartered in Shenzhen, China.

Which VCs invest in companies like Bloomage Gag?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back companies at Bloomage Gag's stage. Their profiles are linked below.

Raising like Bloomage Gag? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.